Thomas Pfister
Overview
Explore the profile of Thomas Pfister including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
549
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sehner C, Bernier T, Blum K, Clemann N, Glogovac M, Hawkins W, et al.
Regul Toxicol Pharmacol
. 2024 May;
150:105649.
PMID: 38782234
Permitted Daily Exposure Limits (PDEs) are set for Active Pharmaceutical Ingredients (APIs) to control cross-contamination when manufacturing medicinal products in shared facilities. With the lack of official PDE lists for...
2.
Leyens L, Northcott C, Maloney L, McCarthy M, Dokuzova N, Pfister T
Digit Biomark
. 2024 Jan;
8(1):1-12.
PMID: 38222479
Background: Developments in the field of digital measures and digitally derived endpoints demand greater attention on globally aligned approaches to enhance digital measure acceptance by regulatory authorities and health technology...
3.
Howard L, Rosenkranz S, Frantz R, Hemnes A, Pfister T, Hsu Schmitz S, et al.
Chest
. 2022 Sep;
163(2):407-418.
PMID: 36089068
Background: Reduced daily life physical activity (DLPA) in pulmonary arterial hypertension (PAH) contributes to a poor quality of life. Research Question: Can actigraphy be used to assess changes in DLPA...
4.
Watson G, Sanz-Garcia E, Zhang W, Liu Z, Yang S, Wang B, et al.
J Immunother Cancer
. 2022 Jun;
10(6).
PMID: 35705312
Background: Recent studies have demonstrated that T cells can induce vasodilation in a choline-acetyltransferase dependent manner, leading to an increase in T cell migration to infected tissues in response to...
5.
Deriving harmonised permitted daily exposures (PDEs) for paracetamol (acetaminophen) CAS #: 103-90-2
Gromek K, Hawkins W, Bernier T, Sehner C, Zeller E, Schwind M, et al.
Regul Toxicol Pharmacol
. 2020 Jun;
115:104692.
PMID: 32522580
In the pharmaceutical industry, cleaning criteria are required for multipurpose manufacturing facilities. These Health Based Exposure Limits (HBELs), also called permitted daily exposures (PDEs) values, are derived from toxicological and...
6.
Straub J, Oldenkamp R, Pfister T, Haner A
Environ Toxicol Chem
. 2019 Jun;
38(10):2259-2278.
PMID: 31225916
An environmental risk assessment is presented for mycophenolic acid (MPA), an immunosuppressive pharmaceutical used for prevention of organ rejection, and its prodrug mycophenolate mofetil (MPM). Mycophenolic acid will not significantly...
7.
Frost A, Janmohamed M, Fritz J, McConnell J, Poch D, Fortin T, et al.
J Heart Lung Transplant
. 2018 Nov;
38(1):43-50.
PMID: 30391194
Background: A long-term trial showed that the oral prostacyclin (PGl) receptor (IP) agonist, selexipag, delayed disease progression in patients with pulmonary arterial hypertension (PAH). Transition to selexipag in patients treated...
8.
Barle E, Pfister T, Fux C, Rothlisberger D, Jere D, Mahler H
Regul Toxicol Pharmacol
. 2018 Oct;
101:29-34.
PMID: 30367903
A toxicological evaluation to determine the product specific permitted daily exposure (PDE) value is an accepted method to determine a safe limit for the carry-over of product residues in multipurpose...
9.
Reichard J, Maier M, Naumann B, Pecquet A, Pfister T, Sandhu R, et al.
Regul Toxicol Pharmacol
. 2016 May;
79 Suppl 1:S67-78.
PMID: 27224509
The purpose of this paper is to describe the use of toxicokinetic (TK) and toxicodynamic (TD) data in setting acceptable daily exposure (ADE) values and occupational exposure limits (OELs). Use...
10.
Sussman R, Naumann B, Pfister T, Sehner C, Seaman C, Weideman P
Regul Toxicol Pharmacol
. 2016 May;
79 Suppl 1:S57-66.
PMID: 27221789
Acceptable daily exposures (ADEs) are established to determine the quantity of one drug substance that can contaminate another drug product without causing harm to the patient. An important part in...